Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Future Oncology

• Publication date

  2010-12-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/fon.10.144PMID 21142858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer

  2010cited by this paper
• p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803

  2009cited by this paper
• Blockade of Protein Geranylgeranylation Inhibits Cdk2-Dependent p27Kip1 Phosphorylation on Thr187 and Accumulates p27Kip1 in the Nucleus: Implications for Breast Cancer Therapy

  2009cited by this paper
• A Cohort Study of p27 Localization in Colon Cancer, Body Mass Index, and Patient Survival

  2009cited by this paper
• Obstructing Shedding of the Immunostimulatory MHC Class I Chain–Related Gene B Prevents Tumor Formation

  2009cited by this paper
• p27Kip1 as a prognostic factor in breast cancer: a systematic review and meta-analysis

  2009cited by this paper
• Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer

  2008cited by this paper
• Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer

  2008cited by this paper
• The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

  2008cited by this paper
• Prognostic impact of Skp2 and p27 in human breast cancer

  2006cited by this paper
• Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer

  2006cited by this paper
• Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.

  2006cited by this paper
• Significance of skp2 expression in primary breast cancer.

  2006cited by this paper
• p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.

  2006cited by this paper
• Cyclin-dependant kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer

  2006cited by this paper
• Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.

  2005cited by this paper
• Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.

  2005cited by this paper
• Subcellular Localization and Protein Levels of Cyclin-Dependent Kinase Inhibitor p27 Independently Predict for Survival in Epithelial Ovarian Cancer

  2005cited by this paper
• RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells

  2005cited by this paper
• p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs.

  2005cited by this paper
• The expression of the ubiquitin ligase subunit Cks1 in human breast cancer

  2005cited by this paper
• Loss of E‐cadherin and p27 expression is associated with head and neck squamous tumorigenesis

  2005cited by this paper
• Loss of the Cyclin-dependent Kinase Inhibitor 27Kq Protein in Human Prostate Cancer Correlates with Tumor Grade’

  2005cited by this paper
• Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.

  2005cited by this paper
• Small interfering RNA targeting of S phase kinase–interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation

  2005cited by this paper
• Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors.

  2004cited by this paper
• Determination of Molecular Marker Expression Can Predict Clinical Outcome in Colon Carcinomas

  2004cited by this paper
• Prognostic Significance of p27kip-1 Expression in Colorectal Adenocarcinomas Is Associated with Tumor Stage

  2004cited by this paper
• The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer

  2004cited by this paper
• Prognostic Value of p27, p53, and Vascular Endothelial Growth Factor in Dukes A and B Colon Cancer Patients Undergoing Potentially Curative Surgery

  2004cited by this paper
• Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.

  2003cited by this paper
• Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma.

  2003cited by this paper
• Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer

  2003cited by this paper
• Expression of p27kip1 in breast cancer and its prognostic significance

  2003cited by this paper
• High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.

  2003cited by this paper
• Novel p27kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions

  2003cited by this paper
• Estrogens Down-regulate p27Kip1 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway*

  2003cited by this paper
• Decreased immunoreactivity for p27 protein in patients with early‐stage breast carcinoma is correlated with HER‐2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status

  2003cited by this paper
• Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer

  2002cited by this paper
• PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization

  2002cited by this paper
• Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.

  2002cited by this paper
• Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest.

  2002cited by this paper
• The SCF ubiquitin ligase: an extended look.

  2002cited by this paper
• Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.

  2002cited by this paper
• Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

  2002cited by this paper
• 5-FU improves p27-related poor prognosis in patients with Astler-Coller B2-C colorectal carcinoma.

  2002cited by this paper
• Altered p27Kip1 Phosphorylation, Localization, and Function in Human Epithelial Cells Resistant to Transforming Growth Factor β-Mediated G1 Arrest

  2002cited by this paper
• Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.

  2001cited by this paper
• A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase

  2001cited by this paper
• Cyclin-Dependent Kinase Inhibitor P27Kip1 Is Required for Mouse Mammary Gland Morphogenesis and Function

  2001cited by this paper
• Skp2 is oncogenic and overexpressed in human cancers

  2001cited by this paper
• Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer.

  2001cited by this paper
• Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas.

  2001cited by this paper
• Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas

  2001cited by this paper
• Low expression of p27Kip1, a cyclin‐dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma

  2001cited by this paper
• High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.

  2001cited by this paper
• Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

  2000cited by this paper
• Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum--a comparative clinicopathologic and molecular analysis.

  2000cited by this paper
• Increased expression levels of cyclin-dependent kinase inhibitor p27 correlate with good responses to platinum-based chemotherapy in non-small cell lung cancer.

  2000cited by this paper
• p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.

  2000cited by this paper
• Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.

  2000cited by this paper
• Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia

  2000cited by this paper
• p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up.

  2000cited by this paper
• p27KIP1: androgen regulation and prognostic significance in prostate cancer.

  2000cited by this paper
• The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy.

  2000cited by this paper
• The ubiquitin system

  2000cited by this paper
• Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.

  2000cited by this paper
• Prognostic Significance of p27kip1 Protein Expression and Spontaneous Apoptosis in Patients with Colorectal Adenocarcinomas

  2000cited by this paper
• p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long‐term follow‐up

  2000cited by this paper
• Immunohistochemical Analysis of Ki-67, p53, p21, and p27 in Benign and Malignant Apocrine Lesions of the Breast: Its Correlation to Histologic Findings in 43 Cases

  2000cited by this paper
• SCF and Cullin/Ring H2-based ubiquitin ligases.

  1999cited by this paper
• p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

  1999cited by this paper
• Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation

  1999cited by this paper
• p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.

  1999cited by this paper
• Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.

  1999cited by this paper
• Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients

  1999cited by this paper
• The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.

  1999cited by this paper
• Absence of the Cell Cycle Inhibitor p27Kip1 Protein Predicts Poor Outcome in Patients With Stage I-III Colorectal Cancer

  1999cited by this paper
• Prognostic significance of p27Kip1 expression in colorectal cancer: a clinico‐pathological characterization

  1999cited by this paper
• Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors.

  1999cited by this paper
• Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras.

  1999cited by this paper
• Prognostic role of p27Kip1 and apoptosis in human breast cancer

  1999cited by this paper
• SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

  1999cited by this paper
• Cyclin‐dependent kinase inhibitor p27Kipl expression and interaction with other cell cycle‐associated proteins in mammary carcinoma

  1999cited by this paper
• Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.

  1998cited by this paper
• Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases.

  1998cited by this paper
• Human CUL1 forms an evolutionarily conserved ubiquitin ligase complex (SCF) with SKP1 and an F-box protein.

  1998cited by this paper
• p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas.

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

  1997cited by this paper
• Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer

  1997cited by this paper
• F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex.

  1997cited by this paper
• Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.

  1997cited by this paper
• The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.

  1997cited by this paper
• Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

  1997cited by this paper
• p27 expression and gastric carcinoma

  1997cited by this paper
• High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.

  1997cited by this paper
• A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.

  1996cited by this paper
• Translational Control of p27Kip1 Accumulation During the Cell Cycle

  1996cited by this paper
• Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

  1996cited by this paper

• Cyclin-dependent kinase inhibitors for the treatment of lung cancer

  2020cites this paper
• An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers.

  2018cites this paper
• FoxM1: Repurposing an oncogene as a biomarker.

  2017cites this paper
• Upregulation of p27Kip1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV3 cells.

  2016cites this paper
• A Dynamical Framework for the All-or-None G1/S Transition

  2016cites this paper
• E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.

  2016cites this paper
• The prognostic of p27kip1 in ovarian cancer: a meta-analysis

  2015cites this paper
• Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1

  2015cites this paper
• The history and future of targeting cyclin-dependent kinases in cancer therapy

  2015cites this paper
• Bases moleculars de l’activitat antitumoral de la lenalidomida en el limfoma de cèl•lules del mantell

  2014cites this paper
• Progesterone Enhances Calcitriol Antitumor Activity by Upregulating Vitamin D Receptor Expression and Promoting Apoptosis in Endometrial Cancer Cells

  2013cites this paper
• Identification of novel tumor biomarkers for sensitivity to radio- and chemotherapy of lung cancer based on genomic analyses

  2013cites this paper
• p27Kip1 V109G Polymorphism and Cancer Risk: A Systematic Review and Meta-Analysis

  2012cites this paper
• Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer.

  2012cites this paper
• miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence

  2012cites this paper
• Improved Statistical Analysis for Array CGH-Based DNA Copy Number Aberrations

  2011cites this paper
• Inter-ethnic differences in lymphocyte sensitivity to glucocorticoids reflect variation in transcriptional response

  2011cites this paper
• Upregulation of p 27 Kip 1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV 3 cells

  year unknowncites this paper